GBI-268

N/A

Report date: 2026/05/22 20:01:29
NME

Base Information

Drug NameGBI-268
Drug Alias NameGBI268GBI-268
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsAcute PainPainPain, Postoperative +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaPhase 3 Clinical
Originator CompaniesSuzhou Zhiyao Biotechnology Co Ltd
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesSuzhou Zhiyao Biotechnology Co LtdGuangzhou Zhiyao Biotechnology Co Ltd
Inactive CompaniesN/A
Active IndicationsAcute PainPainPain, Postoperative +[4] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A